These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16541799)

  • 1. [Protective mechanism against oxidative stress by Keap1/Nrf2 pathway].
    Itoh K
    Seikagaku; 2006 Feb; 78(2):79-92. PubMed ID: 16541799
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of oxidative stress by the Keap1-Nrf2 pathway.
    Stewart JD; Hengstler JG; Bolt HM
    Arch Toxicol; 2011 Apr; 85(4):239. PubMed ID: 21431330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disease regulation by Nrf2 antioxidant system].
    Itoh K
    Seikagaku; 2009 Jun; 81(6):447-55. PubMed ID: 19618868
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2/antioxidant response element signaling pathway.
    Koriyama Y; Chiba K; Yamazaki M; Suzuki H; Muramoto K; Kato S
    J Neurochem; 2010 Oct; 115(1):79-91. PubMed ID: 20681953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles.
    Itoh K; Tong KI; Yamamoto M
    Free Radic Biol Med; 2004 May; 36(10):1208-13. PubMed ID: 15110385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression.
    Kabaria S; Choi DC; Chaudhuri AD; Jain MR; Li H; Junn E
    Free Radic Biol Med; 2015 Dec; 89():548-56. PubMed ID: 26453926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage.
    Cao TT; Ma L; Kandpal G; Warren L; Hess JF; Seabrook GR
    J Neurochem; 2005 Oct; 95(2):406-17. PubMed ID: 16092930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Nrf2 in oxidative stress-induced endothelial injuries.
    Chen B; Lu Y; Chen Y; Cheng J
    J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive promise of targeting the Nrf2 pathway.
    Yates MS; Kensler TW
    Drug News Perspect; 2007 Mar; 20(2):109-17. PubMed ID: 17440634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers.
    Satoh T; Okamoto SI; Cui J; Watanabe Y; Furuta K; Suzuki M; Tohyama K; Lipton SA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):768-73. PubMed ID: 16407140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
    Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuzzy complex formation between the intrinsically disordered prothymosin α and the Kelch domain of Keap1 involved in the oxidative stress response.
    Khan H; Cino EA; Brickenden A; Fan J; Yang D; Choy WY
    J Mol Biol; 2013 Mar; 425(6):1011-27. PubMed ID: 23318954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
    Kim HJ; Vaziri ND
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of Keap1-Nrf2 pathway expression after experimental intracerebral haemorrhage: correlation with brain oedema and neurological deficit.
    Shang H; Yang D; Zhang W; Li T; Ren X; Wang X; Zhao W
    Free Radic Res; 2013 May; 47(5):368-75. PubMed ID: 23438812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
    Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.